Fungus medicament for preventing postoperative cancer recurrence and production method thereof

A production method and fungal technology, which can be used in drug combinations, pharmaceutical formulations, plant/algae/fungus/moss components, etc., to solve problems such as damage to healthy cells and functions of cancer cells
CN103463253BInactive Publication Date: 2015-03-18CHANGDE YONGCHUNTANG BIOTECH

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
CHANGDE YONGCHUNTANG BIOTECH
Publication Date
2015-03-18
Estimated Expiration
Not applicable · inactive patent
Patent Text Reader

Abstract

The invention discloses a fungus medicament for preventing postoperative cancer recurrence and a production method thereof. The fungus medicament for preventing postoperative cancer recurrence is prepared by the following raw materials in parts by weight: 23 parts of mythic fungus wall-broken spore powder, 13 parts of mythic fungus extract, 2 parts of agaricus brasiliensis extract, 3 parts of polyporus extract, 1 part of cordyceps sinensis extract, 12 parts of hedyotis diffusa extract and 15 parts of barbat skullcap extract; also the fungus medicament additionally comprises 1 part of ginseng extract and 5 parts of dog meat extract. The production method comprises: uniformly mixing the above extracts with mythic fungus wall-broken spore powder, drying, pulverizing and processing into capsules. The key point of the fungus medicament of the invention is that: according to the theories of traditional Chinese medicine, traditional Chinese medicine syndrome differentiation treatment and 'monarch and minister, assistant and guide', the above six traditional Chinese medicines are subjected to scientific compatibility, so that an effective medicine combination is established. Mice experiments prove that the fungus medicament has substantial cancer inhibiting effect and almost does not have any toxic and side effects on human body. The advantage that the fungus medicament belongs to a nontoxic immunization activator is precisely not owned by many anticancer cancer-treating chemotherapeutic medicaments and other immunization activators.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to a medicine for treating cancer, that is, a fungal medicine for preventing postoperative recurrence of cancer and a production method thereof. Background technique

[0002] Within two years after cancer surgery, the chances of recurrence and metastasis are relatively high. Therefore, patients need to be checked regularly, and their life and diet should be adjusted appropriately. At present, there is no better way to prevent recurrence or metastasis of cancer after surgery. Standard adjuvant chemotherapy and radiotherapy after surgery can reduce the recurrence and metastasis of cancer or prolong the time of recurrence and metastasis, but there is still the possibility of recurrence and metastasis. , Postoperative cancer patients need to be reexamined every 3 to 4 months, and given drips of anticancer drugs, hospitalized for about 10 days, and this frequency should be maintained for at least two years; after two years, it can be ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More